MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Refract vs HubSpot Sales

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Refract or HubSpot Sales? If you wish to get a easy way to find out which Sales Tools product is better, our unique system gives Refract a score of 6.9 and HubSpot Sales a score of 9.8 for all round quality and performance. In addition, Refract is rated at N/A%, while HubSpot Sales is rated N/A% for their user satisfaction level.

You can also review their product details, including modules, tools, options, plans, costs, and more. Check if the application lets you to customize at least part of its funnels to guarantee it complements your own business workflows.

People who don't have much time or could use a Sales Management Software recommendation from our experts may want to examine these top choices for this year: HubSpot Sales Hub, Freshsales, monday.com sales CRM.

In case you are still having doubts about which app will perform best for your company it might be a sound idea to take a look at each service’s social metrics. These metrics are quite often a sign of how popular every app is and how wide is its online presence. For example Refract Twitter profile has currently 1423 followers. At the same time HubSpot Sales Twitter is followed by 791890 people.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.